| Literature DB >> 28358315 |
Elisavet Tsakelidou1, Christina Virgiliou2, Lemonia Valianou3, Helen G Gika4, Nikolaos Raikos5, Georgios Theodoridis6.
Abstract
The effect of endogenous interferences of serum in multi-targeted metabolite profiling HILIC-MS/MS analysis was investigated by studying different sample preparation procedures. A modified QuEChERS dispersive SPE protocol, a HybridSPE protocol, and a combination of liquid extraction with protein precipitation were compared to a simple protein precipitation. Evaluation of extraction efficiency and sample clean-up was performed for all methods. SPE sorbent materials tested were found to retain hydrophilic analytes together with endogenous interferences, thus additional elution steps were needed. Liquid extraction was not shown to minimise matrix effects. In general, it was observed that a balance should be reached in terms of recovery, efficient clean-up, and sample treatment time when a wide range of metabolites are analysed. A quick step for removing phospholipids prior to the determination of hydrophilic endogenous metabolites is required, however, based on the results from the applied methods, further studies are needed to achieve high recoveries for all metabolites.Entities:
Keywords: endogenous metabolites; sample preparation; serum; targeted metabolomics
Year: 2017 PMID: 28358315 PMCID: PMC5487984 DOI: 10.3390/metabo7020013
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Target metabolites per class of compounds determined in serum by the applied analytical method.
| Class | Metabolites | |
|---|---|---|
| Hypoxanthine | Theobromine | |
| Caffeine | Thymidine | |
| Cotinine | Uracil | |
| Inosine | Uridine | |
| Nicotinamide | Xanthine | |
| Pyridoxine | ||
| Benzoic acid | Hippuric acid | |
| 2-Hydroxyisovaleric acid | Lactic acid | |
| 2-Hydroxyisobutyric acid | Pyroglutamic acid | |
| g-Aminobutyric acid | Pyruvic acid | |
| Putrescine | ||
| Alanine | Proline | |
| Glycine | Tryptophan | |
| Leucine | Tyrosine | |
| Methionine | Valine | |
| Phenylalanine | Ιsoleucine | |
| Acetylcarnitine | Lysine | |
| Arginine | Thiamine | |
| Betaine | Trimethylamine-n-oxide | |
| Choline | ||
| Aspartic acid | Glutamic acid | |
| Asparagine | Ornithine | |
| Creatine | Threonine | |
| Creatinine | Sarcosine | |
| Glutamine | Serine | |
| Hypotaurine | Taurine | |
| 3-Methylhistidine | ||
| Galactose | Lactose | |
| Glucose | Ribose | |
Figure 1Schematic representation of the sample treatment protocols applied in the study indicating the steps needed prior to LC-MS/MS analysis, (a) standard protein precipitation procedure; (b) Dispersive-Solid Phase Extraction (d-SPE) (QuEChERS); (c) Liquid–Liquid Extraction (LLE); (d) HybridSPE.
Figure 2Plot showing the number of detected compounds (bars) and the sum of their areas (line) in the extract of pooled serum sample at different Hybrid SPE conditions.
Figure 3Pearson correlation heat-map indicating the response of the detected metabolites under PPT treatment and different HybridSPE conditions. Colour coding: signal response (peak area) increases from light to dark blue. Hierarchical clustering shows metabolites with similar trends with the applied protocols.
Figure 4Distribution of recovery values for the 53 analytes under optimum HybridSPE conditions at (a) high and (b) low concentration. The respective recovery values for simple PPT are shown in (c) and (d) for high and low concentration in spiked pooled serum.
Figure 5Overlay extracted ion chromatograms (m/z 184) from full scan analysis of samples after PPT and HybridSPE procedures.
Comparison of the final selected HybridSPE protocol with the standard PPT in terms of matrix effect (ME). Retention time of target metabolites in bold indicates elution of analyte in the area of phospholipid elution region.
| Analyte | Rt (min) | MF* | |
|---|---|---|---|
| Conventional PPT | HybridSPE | ||
| 2-Hydroxyisobutyric acid | 7.53 | 1.20 | 0.97 |
| 2-Hydroxyisovaleric acid | 5.4 | 1.00 | 1.02 |
| 3-methylhistidine | 19.32 | 1.13 | 1.22 |
| Acetylcarnitine | 0.96 | 0.92 | |
| Alanine | 15.91 | 1.12 | 1.09 |
| Galactose | 12.08 | 0.83 | 0.86 |
| Arginine | 21.84 | 2.62 | 1.75 |
| Asparagine | 18.29 | 1.04 | 1.04 |
| Aspartic acid | 21.37 | 0.99 | 0.80 |
| Betaine | 12.11 | 0.73 | 0.79 |
| Caffeine | 0.87 | 0.77 | 0.80 |
| Choline | 6.72 | 0.95 | 0.91 |
| Cotinine | 0.96 | 0.87 | |
| Creatine | 0.73 | 0.85 | |
| Creatinine | 0.92 | 0.77 | |
| g-aminobutyric acid | 16.69 | 1.01 | 0.88 |
| Glucose | 0.62 | 1.07 | |
| Glutamic acid | 20.83 | 1.05 | 1.07 |
| Glutamine | 17.65 | 1.32 | 1.31 |
| Glycine | 16.86 | 1.36 | 1.29 |
| Hippuric acid | 1.10 | 1.14 | |
| Hypoxanthine | 0.89 | 0.91 | |
| Inosine | 1.24 | 1.07 | |
| Ιsoleucine | 13.27 | 2.25 | 1.87 |
| Lactic acid | 11.12 | 0.48 | 0.68 |
| Leucine | 12.82 | 1.49 | 1.42 |
| Lysine | 22.3 | 1.47 | 1.27 |
| Methionine | 14.00 | 1.09 | 0.88 |
| Valine | 14.26 | 0.98 | 1.00 |
| Ornithine | 22.52 | 1.42 | 0.74 |
| Phenylalanine | 12.54 | 1.22 | 1.19 |
| Proline | 0.81 | 1.09 | |
| Putrescine | 20.84 | 1.00 | 0.83 |
| Pyridoxine | 1.00 | 0.89 | |
| Pyroglutamic acid | 14.78 | 1.07 | 1.02 |
| Pyruvic acid | 7.06 | 0.89 | 0.84 |
| Ribose | 0.87 | 0.93 | |
| Sarcosine | 15.1 | 0.90 | 1.04 |
| Serine | 17.78 | 1.21 | 1.02 |
| Taurine | 14.24 | 1.04 | 0.86 |
| Theobromine | 0.93 | 0.44 | |
| Thiamine | 11.57 | 1.12 | 1.06 |
| Threonine | 16.62 | 1.13 | 1.11 |
| Thymidine | 1.02 | 0.64 | |
| Trimethylamine- | 12.64 | 1.02 | 1.01 |
| Tryptophan | 12.66 | 1.18 | 1.10 |
| Tyrosine | 14.42 | 1.01 | 1.05 |
| Uracil | 1.82 | 1.13 | 0.83 |
| Uridine | 0.85 | 0.96 | |
| Xanthine | 7.28 | 1.10 | 1.04 |
| Benzoic acid | 1.63 | 0.20 | 0.28 |
| Hypotaurine | 15.62 | 1.32 | 1.24 |
| Lactose | 18.31 | 1.01 | 1.16 |
| Nicotinamide | 1.16 | 1.10 | 0.86 |
* Matrix effect is expressed as matrix factor (MF)